噻嗪类激发试验鉴别原发性与高钙尿症相关甲状旁腺功能亢进的评估
单中心观察性回顾性队列研究纳入25例高钙尿症、甲状旁腺激素升高、血钙高正常或升高的成人患者,评估噻嗪类激发试验(TCT)在临床实践中的鉴别作用。以TCT为基础的工作诊断原发性甲状旁腺功能亢进(PHPT)的灵敏度为81.8%,特异度为77.8%,正确估计最终诊断的似然比为3.68。PHPT患者白蛋白校正钙和总血钙升高幅度大于特发性高钙尿症所致继发性甲状旁腺功能亢进(SHPT-IH)患者,其他参数无显著差异。
要点
- TCT后PHPT患者白蛋白校正钙升高幅度大于SHPT-IH患者(+0.11±0.10 vs +0.0071±0.10 mmol/L,P=.025)。
- TCT后PHPT患者总血钙升高幅度大于SHPT-IH患者(+0.14±0.12 vs +0.012±0.15 mmol/L,P=.024)。
- 以TCT为基础的工作诊断PHPT灵敏度81.8%、特异度77.8%、似然比3.68。
核心结论
- TCT可基于血钙升高帮助鉴别PHPT与SHPT-IH,其他参数在两组间无显著差异。
- 需更大规模前瞻性试验进一步明确TCT的诊断潜力、最合适的生化结局变量及决策切点。
研究设计与样本
- 单中心观察性回顾性队列研究,2017年1月至2023年11月于比利时根特大学医院内分泌科门诊开展。
- 纳入25例高钙尿症、甲状旁腺激素升高、血钙高正常或升高的成人患者,均接受TCT。
- 结局指标为试验前后的血清及尿液生化参数、临床与影像结局、治疗及随访。
主要发现
- 以TCT为基础的工作诊断PHPT患者白蛋白校正钙升高幅度大于SHPT-IH患者(+0.11±0.10 vs +0.0071±0.10 mmol/L,P=.025)。
- 以TCT为基础的工作诊断PHPT患者总血钙升高幅度大于SHPT-IH患者(+0.14±0.12 vs +0.012±0.15 mmol/L,P=.024)。
- 以TCT为基础的工作诊断PHPT灵敏度81.8%、特异度77.8%、似然比3.68。
- 尿钙排泄、PTH、钙磷比、PTH抑制率及甲状旁腺功能指数在PHPT与SHPT-IH患者间无显著差异。
关键数值与推荐
- 以TCT为基础的工作诊断PHPT的灵敏度为81.8%,特异度为77.8%,似然比为3.68。
- PHPT患者白蛋白校正钙变化+0.11±0.10 mmol/L vs SHPT-IH患者+0.0071±0.10 mmol/L(P=.025)。
- PHPT患者总血钙变化+0.14±0.12 mmol/L vs SHPT-IH患者+0.012±0.15 mmol/L(P=.024)。
临床怎么用
- TCT可基于血清钙升高协助区分PHPT与SHPT-IH。
- 尿钙排泄、PTH、钙磷比、PTH抑制率及甲状旁腺功能指数在本研究中未显示组间差异。
局限性
- 单中心观察性回顾性队列研究。
- 样本量为25例。
- 需更大规模前瞻性试验进一步明确TCT的诊断潜力、最合适的生化结局变量及决策切点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Treatment of primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism due to idiopathic hypercalciuria (SHPT-IH) is markedly different. Robust diagnostic tools to differentiate between both entities are however lacking. OBJECTIVE: Evaluate the thiazide challenge test (TCT) in clinical practice, its aid in clinical decision making, and evaluate the accuracy (sensitivity, specificity) and potentially useful parameters of the TCT. METHODS: Monocentric observational retrospective cohort study from January 2017 to November 2023 in an outpatient Endocrinology department, Ghent University Hospital (Belgium). Twenty-five adult patients with hypercalciuria, elevated parathyroid hormone (PTH), and high-normal or elevated serum calcium underwent a TCT. Outcome measures were serum, urinary biochemical parameters before and after testing, clinical and imaging outcomes, treatment, and follow-up. RESULTS: Patients with a TCT-based working diagnosis of PHPT show greater increases in albumin-adjusted calcium and total serum calcium concentration than patients with SHPT-IH (+0.11 ± 0.10 vs +0.0071 ± 0.10 mmol/L; P = .025 and +0.14 ± 0.12 vs +0.012 ± 0.15 mmol/L; P = .024, respectively). The TCT-based working diagnosis of PHPT has a sensitivity of 81.8%, a specificity of 77.8%, and a likelihood ratio of 3.68 of estimating a correct final diagnosis. Urinary calcium excretion, PTH, calcium-phosphorous ratio, PTH inhibition rate, and the parathyroid function index do not differ significantly in patients with PHPT compared with those with SHPT-IH. CONCLUSION: The TCT aids in discriminating patients with PHPT from those with SHPT-IH based on a rise in serum calcium. Other parameters are not different between both groups. Larger prospective trials are necessary to further define the diagnostic potential of the TCT, its most appropriate biochemical outcome variables, and decision cut-offs.
引用
- Verly E, Lapauw B, Verroken C, et al. Evaluation of the Thiazide Challenge Test to Differentiate Primary From Hypercalciuria-Related Hyperparathyroidism. J Clin Endocrinol Metab. 2025. PMID: 38605120. doi:10.1210/clinem/dgae239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。